Substituted piperazines as CB1 antagonists
Details for Australian Patent Application No. 2005311930 (hide)
International Classifications
Event Publications
21 June 2007 PCT application entered the National Phase
PCT publication WO2006/060461 Priority application(s): WO2006/060461
6 August 2009 Application Accepted
Published as AU-B-2005311930
3 December 2009 Standard Patent Sealed
11 October 2012 Application for Amendment
The nature of the amendment is: Amend the Patentee to read Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005311931-Compositions and methods of treating irritation and kit therefor
2005311929-Treating acute exacerbations of asthma using a ketolide
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser